Pulmonx Corporation (LUNG) Tops Q1 EPS by 3c

Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.36), $0.03 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $22.5 million versus the consensus estimate of $22.03 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• ICICI Bank (ICICIBC:IN) (IBN) PT Raised to INR2,000 at Goldman Sachs
• Hindustan Unilever Ltd (HUVR:IN) PT Lowered to INR2,115 at Kotak
• Barclays Reiterates Overweight Rating on Wizz Air Holdings (WIZZ:LN) (WZZAF)